πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Gritstone bio, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

ImmunityBio, Inc.

ImmunityBio, Inc. logo
Market Cap: High
Employees: Medium

Therapies and Vaccines

Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.

Tags: biotechnology, cancer, cell therapy, immunotherapy, infectious diseases, vaccines

Symbol: IBRX

Recent Price: $2.68

Industry: Biotechnology

CEO: Mr. Richard Gerald Adcock

Sector: Healthcare

Employees: 622

Address: 3530 John Hopkins Court, San Diego, CA 92121

Phone: 858 633 0300

Last updated: 2024-12-31

INmune Bio, Inc.

INmune Bio, Inc. logo
Market Cap: Low
Employees: Lowest

INKmune

INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.

Tags: Alzheimer's disease, chronic inflammation, hematologic malignancies, immunotherapy, solid tumors

Symbol: INMB

Recent Price: $4.65

Industry: Biotechnology

CEO: Dr. Raymond Joseph Tesi M.D.

Sector: Healthcare

Employees: 11

Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432

Phone: 858 964 3720

Last updated: 2024-12-31

Tourmaline Bio, Inc.

Tourmaline Bio, Inc. logo
Market Cap: Medium
Employees: Low

medicines for immune diseases

Tourmaline Bio, Inc. is a clinical biotechnology company focused on developing medicines for patients with life-altering immune diseases, such as Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).

Tags: ASCVD, TED, biotechnology, clinical development, immune diseases

Symbol: TRML

Recent Price: $20.08

Industry: Biotechnology

CEO: Dr. Sandeep C. Kulkarni M.D.

Sector: Healthcare

Employees: 70

Address: 27 West 24th Street, New York, NY 10010

Phone: 646-481-9832

Last updated: 2024-12-31

Agenus Inc.

Agenus Inc. logo
Market Cap: Low
Employees: Medium

Retrocyte Display

Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.

Tags: antibody expression, cancer treatment, clinical trials, immuno-oncology, vaccine development

Symbol: AGEN

Recent Price: $2.69

Industry: Biotechnology

CEO: Dr. Garo H. Armen Ph.D.

Sector: Healthcare

Employees: 389

Address: 3 Forbes Road, Lexington, MA 02421-7305

Phone: 781 674 4400

Last updated: 2024-12-31

Belite Bio, Inc

Belite Bio, Inc logo
Market Cap: High
Employees: Lowest

LBS-008

Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.

Tags: Stargardt diseases, biopharmaceutical, clinical-stage, drug development, liver disease, macular degeneration, phase 3, therapeutics

Symbol: BLTE

Recent Price: $61.97

Industry: Biotechnology

CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.

Sector: Healthcare

Employees: 20

Address: 5820 Oberlin Drive, San Diego, CA 92121

Phone: 858-246-6240

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

IGALMI

Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.

Tags: agitation treatment, artificial intelligence, biopharmaceutical, clinical trials, immuno-oncology, neuroscience

Symbol: BTAI

Recent Price: $0.37

Industry: Biotechnology

CEO: Dr. Vimal D. Mehta Ph.D.

Sector: Healthcare

Employees: 74

Address: 555 Long Wharf Drive, New Haven, CT 06511

Phone: 475 238 6837

Last updated: 2024-12-31

Cogent Biosciences, Inc.

Cogent Biosciences, Inc. logo
Market Cap: Medium
Employees: Low

CGT9486

Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.

Tags: biotechnology, genetically defined diseases, precision therapies, tyrosine kinase inhibitor

Symbol: COGT

Recent Price: $7.67

Industry: Biotechnology

CEO: Mr. Andrew R. Robbins M.B.A.

Sector: Healthcare

Employees: 164

Address: 200 Cambridge Park Drive, Cambridge, MA 02140

Phone: 617 945 5576

Last updated: 2024-12-31

Geron Corporation

Geron Corporation logo
Market Cap: High
Employees: Low

Imetelstat

Geron Corporation is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapeutics for myeloid hematologic malignancies, notably through their telomerase inhibitor, imetelstat, which is in Phase 3 clinical trials.

Tags: biopharmaceutical, clinical trials, imetelstat, myeloid hematologic malignancies, telomerase inhibitor

Symbol: GERN

Recent Price: $3.40

Industry: Biotechnology

CEO: Dr. John A. Scarlett M.D.

Sector: Healthcare

Employees: 141

Address: 919 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 473 7700

Leadership

  • John A. Scarlett, M.D., Chairman of the Board, President and Chief Executive Officer
  • Melissa A. Kelly Behrs, Executive Vice President, Business Operations and Chief Alliance Officer
  • Faye Feller, M.D., Executive Vice President, Chief Medical Officer
  • Andrew J. Grethlein, Ph.D., Executive Vice President, Chief Operating Officer
  • Edward Koval, Executive Vice President and Chief Business Officer
  • Shannon T. Odam, Senior Vice President, Chief People Officer
  • Michelle Robertson, Executive Vice President, Chief Financial Officer and Treasurer
  • Scott A. Samuels, Esq., Executive Vice President, Chief Legal Officer and Secretary
  • Jim Ziegler, Executive Vice President, Chief Commercial Officer
  • Gaurav Aggarwal, M.D., Compensation Committee, Strategic Committee (Chair)
  • Dawn C. Bir, Nominating and Corporate Governance Committee (Chair), Compensation Committee
  • V. Bryan Lawlis, Ph.D., Audit Committee, Nominating and Corporate Governance Committee
  • John F. McDonald, Audit Committee, Strategic Committee
  • Susan M. Molineaux, Ph.D., Compensation Committee (Chair), Nominating and Corporate Governance Committee
  • Elizabeth G. O’Farrell, Lead Director, Audit Committee (Chair), Strategic Committee
  • Robert J. Spiegel, M.D., FACP, Compensation Committee, Nominating and Corporate Governance Committee

Last updated: 2024-12-31

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc. logo
Market Cap: Low
Employees: Lowest

GP2

Greenwich Life Sciences, Inc. is a clinical stage biopharmaceutical company focusing on developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers, with a lead product candidate GP2, which aims to prevent breast cancer recurrences.

Tags: GP2, HER2/neu, biopharmaceutical, breast cancer, cancer immunotherapy, clinical trial

Symbol: GLSI

Recent Price: $10.91

Industry: Biotechnology

CEO: Mr. Snehal S. Patel

Sector: Healthcare

Employees: 3

Address: Building 14, Stafford, TX 77477

Phone: 832 819 3232

Last updated: 2024-12-31

Gossamer Bio, Inc.

Gossamer Bio, Inc. logo
Market Cap: Low
Employees: Low

GB002, GB004, GB5121, GB7208

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.

Tags: biopharmaceutical, central nervous system lymphoma, immunology, inflammation, inflammatory bowel disease, multiple sclerosis, oncology, pulmonary arterial hypertension, therapeutics

Symbol: GOSS

Recent Price: $0.88

Industry: Biotechnology

CEO: Mr. Faheem Hasnain

Sector: Healthcare

Employees: 135

Address: 3013 Science Park Road, San Diego, CA 92121

Phone: 858 684 1300

Leadership

  • Faheem Hasnain, Chairman
  • Richard Aranda, M.D., Chief Medical Officer
  • Jeff Boerneke, General Counsel and Secretary
  • Matt Cravets, Senior Vice President, Biometrics
  • Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
  • Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
  • Caryn Peterson, Executive Vice President, Regulatory Affairs
  • Bob Smith, Chief Commercial Officer
  • Christian Waage, Executive Vice President, Technical Operations & Administration
  • Deanna Weber, Senior Vice President, Human Resources
  • Russell J. Cox, Director
  • Thomas Daniel, Director
  • Skye Drynan, Director
  • Sandra Milligan, Director
  • Steven D. Nathan, Director
  • John Quisel, Director

Last updated: 2024-12-31

GRI Bio, Inc.

GRI Bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

GRI-0621, GRI-0803, GRI-0124, GRI-0729, ADAIR, ADMIR

GRI Bio, Inc. is a clinical-stage biopharmaceutical company focusing on the treatment of inflammatory, fibrotic, and autoimmune diseases in the United States, with a diverse pipeline including treatments for idiopathic pulmonary fibrosis and systematic lupus erythematosus.

Tags: autoimmune diseases, biopharmaceutical, clinical-stage, fibrotic diseases, inflammatory diseases

Symbol: GRI

Recent Price: $0.80

Industry: Biotechnology

CEO: Ms. Cristina Gil White

Sector: Healthcare

Employees: 4

Address: 2223 Avenida de la Playa, LA Jolla, CA 92037

Phone: 619 400 1170

Last updated: 2024-12-31

Gritstone bio, Inc.

Gritstone bio, Inc. logo
Market Cap: Lowest
Employees: Low

GRANITE

Gritstone bio, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer and infectious diseases, with lead products including GRANITE, SLATE, and CORAL.

Tags: HIV, SARS-CoV-2, biotechnology, cancer treatment, immunotherapy, infectious diseases

Symbol: GRTS

Recent Price: $0.03

Industry: Biotechnology

CEO: Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.

Sector: Healthcare

Employees: 231

Address: 5959 Horton Street, EmeryVille, CA 94608

Phone: 510 871 6100

Last updated: 2024-12-31

Immunome, Inc.

Immunome, Inc. logo
Market Cap: Medium
Employees: Low

IMM-ONC-01, IMM-BCP-01

Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.

Tags: antibody therapeutics, biopharmaceutical, infectious disease, oncology

Symbol: IMNM

Recent Price: $10.28

Industry: Biotechnology

CEO: Dr. Clay B. Siegall Ph.D.

Sector: Healthcare

Employees: 78

Address: 665 Stockton Drive, Exton, PA 19341

Phone: 610 321 3700

Last updated: 2024-12-31

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. logo
Market Cap: High
Employees: Low

NX-2127, NX-5948, NX-1607, NX-0255

Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.

Tags: BTK degrader, CBL-B inhibitor, biopharmaceutical, cancer, clinical trials, immune disorders

Symbol: NRIX

Recent Price: $18.64

Industry: Biotechnology

CEO: Dr. Arthur T. Sands M.D., Ph.D.

Sector: Healthcare

Employees: 284

Address: 1700 Owens Street, San Francisco, CA 94158

Phone: 415 660 5320

Last updated: 2024-12-31

Instil Bio, Inc.

Instil Bio, Inc. logo
Market Cap: Low
Employees: Lowest

ITIL-168, ITIL-306

Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops cell therapies for treating cancer patients, focusing on autologous tumor infiltrating lymphocyte (TIL) treatments.

Tags: TIL, biopharmaceutical, cancer therapy, cell therapy, clinical-stage

Symbol: TIL

Recent Price: $18.99

Industry: Biotechnology

CEO: Mr. Bronson Crouch

Sector: Healthcare

Employees: 49

Address: 3963 Maple Avenue, Dallas, TX 75219

Phone: 972 499 3350

Last updated: 2024-12-31

Turnstone Biologics Corp.

Turnstone Biologics Corp. logo
Market Cap: Lowest
Employees: Low

TIDAL-01

Turnstone Biologics Corp. is a clinical stage biotechnology company focused on developing medicines for treating and curing patients with solid tumors. Its lead product, TIDAL-01, is in Phase 1 clinical trials for various cancers.

Tags: TILs, biotechnology, clinical stage, immunotherapy, solid tumors

Symbol: TSBX

Recent Price: $0.50

Industry: Biotechnology

CEO: Dr. Sammy J. Farah M.B.A., Ph.D.

Sector: Healthcare

Employees: 82

Address: 9310 Athena Circle, LA Jolla, CA 92037

Phone: 347-897-5988

Last updated: 2024-12-31

Cullinan Oncology, Inc.

Cullinan Oncology, Inc. logo
Market Cap: Medium
Employees: Low

CLN-081

Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Their lead candidate, CLN-081, is in a trial for treating non-small cell lung cancer. The company also has several preclinical products targeting various forms of cancer.

Tags: biopharmaceutical, cancer, clinical trials, immuno-oncology, oncology, therapies

Symbol: CGEM

Recent Price: $12.20

Industry: Biotechnology

CEO: Mr. Nadim Ahmed

Sector: Healthcare

Employees: 85

Address: One Main Street, Cambridge, MA 02142

Phone: 617 410 4650

Last updated: 2024-12-31

Galecto, Inc.

Galecto, Inc. logo
Market Cap: Lowest
Employees: Lowest

GB2064

Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.

Tags: biotechnology, cancer, clinical trials, fibrosis, inflammation, pharmaceutical

Symbol: GLTO

Recent Price: $4.60

Industry: Biotechnology

CEO: Dr. Hans T. Schambye M.D., Ph.D.

Sector: Healthcare

Employees: 13

Address: 75 State Street, Boston, MA 02109

Phone: 457 070 5210

Last updated: 2024-12-31

Granite Construction Incorporated

Granite Construction Incorporated logo
Market Cap: High
Employees: High

Infrastructure and Construction Services

Granite Construction Incorporated operates as an infrastructure contractor and a construction materials producer in the United States, engaging in the construction and rehabilitation of roads, bridges, and other public infrastructure projects, as well as producing aggregates and asphalt.

Tags: Construction, Contractor, Infrastructure, Materials, Public Works

Symbol: GVA

Recent Price: $88.77

Industry: Engineering & Construction

CEO: Mr. Kyle T. Larkin

Sector: Industrials

Employees: 2100

Address: 585 West Beach Street, Watsonville, CA 95076

Phone: 831 724 1011

Leadership

  • Kyle Larkin, President and Chief Executive Officer
  • Staci Woolsey, EVP, Chief Financial Officer
  • Jim Radich, EVP, Chief Operating Officer
  • Craig Hall, SVP, General Counsel, Corporate Compliance Officer, and Secretary
  • Tim Gruber, SVP, Human Resources
  • Brian Dowd, SVP, Construction
  • Brad Estes, SVP, Construction Materials
  • Mike Tatusko, SVP, Construction
  • Brad Williams, SVP, Construction
  • Kim Craig, SVP, Corporate Finance & Treasurer
  • Dave Hulverson, SVP, Safety, Health, Environment, & Quality
  • Erin Kuhlman, SVP, Chief Marketing & Communications Officer
  • Jorge Quezada, Chief Diversity Officer
  • Robert Chase, VP, Corporate Development & Strategy
  • Tracy Coppinger, VP, Enterprise Excellence
  • Jim Grogan, VP, Strategic Initiatives
  • Mike McNally, Board Chair
  • Louis E. Caldera, Former Secretary of the Army
  • Molly C. Campbell, Infrastructure Advisor
  • David C. Darnell, Retired Vice Chairman
  • Carlos M. Hernandez, Retired CEO
  • Alan P. Krusi, Retired President, Strategic Development
  • Celeste B. Mastin, President & CEO
  • Laura M. Mullen, Retired Partner

Last updated: 2024-12-31